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INTRODUCTION
This clinical case illustrates a rare and life-threatening
presentation of celiac disease (CD), a celiac crisis with
neurological symptoms. The diagnosis of celiac crisis should
be included in the differential diagnosis of some types of
diarrhea with serious metabolic disorders to prevent serious
future complications. A large number of celiac patients
remain undiagnosed for years, especially when the clinical
form of the disease is atypical. They are exposed to risks of
acute complications, as in the case reported here, or chronic
complications, such as infertility, osteoporosis and lym-
phoma.
CASE REPORT
A boy aged 4 years and 7 months was admitted to the
emergency room with a chief complaint of unsteady
walking that had started 10 h earlier. He felt drowsy and
dizzy and was hypoactive. Following the neurological
symptoms, he had a large volume of watery diarrhea.
Before that, he was in good health, with no history of
neurological or metabolic disease, fever or abdominal pain.
On admission, the child was dehydrated, but had normal
temperature and blood pressure. His weight was 17 kg (25th
percentile), and his height was 108 cm (50th percentile). The
physical examination showed moderate muscle hypotro-
phy, scarce adiposity, abdominal distention and no viscer-
omegaly. The neurological examination showed unsteady
walking, dysarthria, hand dysmetria and isochoric light
reagent pupils. He had irritability and self-aggressive
behavior. Glasgow coma scale was 15. Drug screening tests
were negative.
The child was born at term; birth weight was normal, and
he was breastfed until 5 months of age. From the age of 2, he
had sporadic diarrhea controlled with a low-fiber diet and
lactose-free milk, and a diagnosis of irritable bowel
syndrome was made. Enteropathogenic agents and blood
in the stools were absent on all occasions. Serology tests for
antigliadin (AGA) and antiendomysium antibodies (EMA)
IgA and IgG were negative for CD at ages 2 and 4.
Laboratory test results showed hyponatremia (133 mEq/
L), hypokalemia (3.1 mEq/L), hyperchloremic metabolic
acidosis (pH 7.2; bicarbonate: 7 mmol/L; BE: –19.9). Serum
chloride was 122 mEq/L, and lactate (,2 mmol/L) and
glucose (85 mg/dL) levels were normal. Blood tests were
normal. Liver and kidney functions were normal (TGO:
46 U/mL; TGP: 35 U/mL; urea: 10 mg/dL; creatinine:
0.3 mg/dL). Levels of serum iron, ferritin, cholesterol and
albumin were extremely low. Stool analyses revealed no
parasites, rare leukocytes and erythrocytes; cultures were
negative and no Clostridium difficile toxins were detected.
Radiographs showed global abdominal distension; cranial
magnetic resonance imaging (MRI), computed tomography
(CT) scans and cerebrospinal fluid tests were normal. Both
sleep and waking electroencephalograms were normal.
Similar episodes were observed four consecutive times at
1-week intervals. Before each admission, the child ingested
large amounts of bread, cakes and pizza. In the first three
hospital admissions, his neurological symptoms faded
within 2 days, but the hyperchloremic metabolic acidosis
persisted without any evident cause. He had received
intravenous hydration and was placed on a low-fiber and
hypoallergenic diet without gluten restriction. The need for
bicarbonate and potassium chlorate was high, so it was
suggested that the loss of potassium and bicarbonate was
probably associated with fecal loss because his kidney
function was normal. During his fourth admission, a
complete investigation for malabsorption was carried out.
Fecal analysis revealed an increased loss of fats. Serum
IgA EMA and IgA anti-tissue transglutaminase antibody
(anti-tTG) was reagent, over 100 U/mL. CD was suspected.
The mucosa magnified by endoscope showed microhemor-
rhage, reduction in duodenal folds and multiple erosions
(Figure 1A and B). Histological examination showed partial
and total villous atrophy, intraepithelial lymphocytes and
increased length crypts (Marsh 3C) (Figure 1C).
After the introduction of a gluten-free diet, the child
improved progressively, and a supplement of folic acid, iron
and calcium was introduced.
DISCUSSION
This is a rare presentation of celiac crisis, with acute ataxia
in a child whose serological blood tests were negative for
CD.
Celiac crisis is the most acute form of CD and has not
been described in Brazil before. It is characterized by
explosive diarrhea, dehydration and severe electrolytic
abnormalities, as was observed in this case.
1,2 It can be fatal
if left untreated.
3 Celiac crisis may complicate the diagnosis
of CD, or it may be the initial symptom of this disease, as in
our patient. Descriptions of neurological disturbances in CD
have increased, but no report has included celiac crisis until
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173now. Gupta et al. first described a celiac crisis in a 30-year-
old woman with acute quadriparesis and attributed the
neurological disturbances to refractory severe hypokale-
mia.
4 Our patient had presented with cerebellar ataxia
before the onset of diarrhea and metabolic abnormalities in
four hospital admissions, which confirmed the neurological
involvement during celiac crisis.
The physiopathology of neurological disturbances in cases
of CD is unknown, but immunological, nutritional, toxic and
metabolic mechanisms have been suggested. Neurological
disturbances occur in 8–10% of adults with CD and are less
frequent in children.
5 Ataxia is the most frequent neurolo-
gical symptom, followed by myoclonias, neuropathies and
dementia. Some authors believe that there is a positive
correlation between gluten sensitivity and cerebellar disease
because of the presence of AGA in patients with neurological
symptoms of unknown etiology.
6 AGA may have a neuro-
toxic effect in CD when they cross the intestinal mucosa
during enteral infections, in case of a ‘‘leaky gut’’, and they
could have a cross-reaction with Purkinje cells.
7 The
neurotoxic effects caused by the increased ingestion of
gluten, in conjunction with the metabolic disturbances
caused by diarrhea, may be the cause of the cerebellar ataxia,
irritability, drowsiness and muscle weakness seen in our
patient. The low serum potassium levels resulting from
excessive loss in feces worsened the weakness and led to
uncoordinated movements, which may explain the high
potassium demand. Vitamin E and vitamin B12 deficiencies,
due to chronic malabsorption, may also cause spine
cerebellar degeneration and peripheral neuropathies.
5
The abrupt increase in gluten ingestion and the recovery
from ataxia and diarrhea by reducing gluten ingestion may
be strongly associated with dosage. The influence of the
amount of gluten on CD is controversial, and no studies
have investigated this in cases of celiac crisis. Fasano et al.
showed that the gluten-induced upregulation of zonulin, an
intestinal peptide involved in the regulation of tight
junctions, is responsible, at least in part, for the aberrant
increase in gut permeability that is characteristic of the early
phase of CD, and it reaches higher levels in the acute phase
of CD.
8 Also, zonulin seems to facilitate the passage of
macromolecules through enterocytes and is responsible
for the increased incidence of autoimmune illnesses in
untreated CD patients. The excessive amount of gluten
ingested by our patient might have led to an increase in
intestinal permeability, according to this mechanism. There-
fore, under normal conditions, the juxtaposed enterocytes
would limit the passage of macromolecules (including
gluten peptides) and avoid the crisis. This explains the
child’s recovery after the reduction in gluten ingestion at the
hospital, without any specific neurological treatment; meta-
bolic acidosis, however, persisted.
From the age of 2, the patient had a satisfactory
nutritional evolution, together with a state of mild malab-
sorption. Breastfeeding might have delayed the clinical
signs and symptoms of CD; or the patient might have
become tolerant to low doses of gluten via intrinsic factors;
or both.
9 The exposure to gluten before the third month, or
its ingestion in large amounts during weaning, may trigger
CD in children with a genetic predisposition. Our patient’s
low exposure to gluten since weaning might not have
reached the level necessary to compromise his intestinal
mucosa and affect his nutritional state. Later, a large
amount of gluten led to uncontrollable diarrhea, and
hypoalbuminemia created conditions for low tolerance to
fluid loss, metabolic acidosis and hypokalemia, all char-
acteristics of celiac crisis.
4
The development of serological markers for CD screening
has facilitated its early diagnosis in risk populations. The
sensitivity of serological EMA and anti-tTG antibodies is
greater than 90%, and these test markers are the best
diagnostic options for CD. Our patient had only AGA and
EMA antibodies, which are not sufficient to diagnose CD
because they are not very accurate in cases of partial villous
atrophy.
10
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